Azam Esmailnejad

1PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 03, 2024
Effectiveness of edaravone in preventing contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A randomized, double-blind trial.

Azam Esmailnejad, Sepideh Zununi Vahed, Seyyedeh Mina Hejazian

Pageof 1